CACNA1D and breast carcinoma: Other studies highlighted that UTMD of miR-133a could inhibit the tumor growth and improve the survival rate in breast cancer mice [38], and UTMD of Cav1.3 siRNA exerted antitumor effects on breast cancer [39].